Testis morphology in rats chronically treated with letrozole, an aromatase inhibitor

Anna Kondarewicz1, Agnieszka Kolasa, Bartosz Zawiślak

  • 1Department of Histology and Embryology, Pomeranian Medical University in Szczecin, Poland. anna_kondarewicz@wp.pl

Insights

Long-term letrozole treatment in rats caused significant testicular damage, including seminiferous epithelium changes and Leydig cell alterations. This highlights the crucial role of estrogens in maintaining testicular morphology and function.

Area of Science:

  • Reproductive biology
  • Endocrinology
  • Histopathology

Background:

  • Estrogens play a vital role in male reproductive health.
  • Letrozole is an aromatase inhibitor that reduces estrogen levels.

Purpose of the Study:

  • To investigate the long-term effects of letrozole-induced estrogen deficiency on rat testis morphology.
  • To assess changes in seminiferous epithelium and interstitial tissue.

Main Methods:

  • Rats were treated with letrozole for six months.
  • Testis morphology was examined histopathologically.
  • Intratesticular and serum estradiol levels were measured.
  • Localization of luteinizing hormone receptor (LH-R)-positive Leydig cells was assessed.

Main Results:

  • Letrozole treatment significantly decreased intratesticular and serum estradiol levels.
  • Morphological changes observed included seminiferous epithelium damage (sloughing of germ cells, vacuolization) and interstitial tissue alterations.
  • Increased lipofuscin accumulation in Leydig cells was noted, resembling aging changes.

Conclusions:

  • Estrogen deficiency induced by letrozole has detrimental effects on testicular structure.
  • Estrogens are essential for maintaining the integrity of seminiferous tubules and interstitial tissue.
  • Long-term letrozole treatment may accelerate testicular aging processes.